Last reviewed · How we verify
NCT04516226
Vaginal Cleansing With Chlorhexidine Gluconate in Women With Preterm Pre-labor Rupture of Membranes
NA trial testing Vaginal cleansing with chlorhexidine gluconate solution in Preterm Premature Rupture of Membrane in 40 participants. Status unknown.
31 December 2024
Quick facts
| Lead sponsor | Albany Medical College |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 August 2020 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Vaginal cleansing with chlorhexidine gluconate solution
Conditions studied
- Preterm Premature Rupture of Membrane — all drugs for Preterm Premature Rupture of Membrane →
Sponsor
Albany Medical College
Who can join
Adults 18 to 50, female only, with Preterm Premature Rupture of Membrane. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Randomized controlled trial studying the use of vaginal cleansing with chlorhexidine gluconate for pregnant women with PPROM (preterm pre labor rupture of membranes). The primary outcome will be pregnancy latency. Secondary outcomes will include various maternal and neonatal outcomes, and inflammatory markers from maternal blood, amniotic fluid, fetal cord blood and placental analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04516226
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Preterm Premature Rupture of Membrane
Currently open trials in the same condition.
- NCT06074601 — MIRACLE of LIFE Study · active not recruiting
Other Albany Medical College trials
Trials by the same sponsor.
- NCT07373093 — Predictors of Measles Vaccine Hesitancy in New York State · completed
- NCT06517901 — Fusion or Cognitive Ultrasound-guided Biopsy to Detect Prostate Cancer · NA · recruiting
- NCT06668766 — Single Lumen Midline Catheter vs Long Peripheral Intravenous Cather for Difficult Intravenous Access in the ED · NA · recruiting
- NCT06677541 — Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients · NA · recruiting
- NCT02703610 — Randomized Trial of Two Analgesics in Elderly ED Patients · Phase 4 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04516226 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Albany Medical College
- Last refreshed: 18 April 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04516226.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing